0921 GMT - Challenging end markets are likely to overhang Clariant's earnings development, Jefferies analysts say in a research note. The Swiss chemical company's net pricing should support relative resilience when compared to its peers, the analysts say. However, its midterm targets appear challenging to meet given the uncertain macro-economy, they say. Jefferies reduces its price target to 9.50 Swiss francs from 10.90 francs, downgrading its recommendation to hold. Shares trade 1.1% lower at 8.36 francs. (nina.kienle@wsj.com)
(END) Dow Jones Newswires
June 16, 2025 05:21 ET (09:21 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.